Nicole Price

Nicole Price is an experienced professional in the pharmaceutical and healthcare sectors, currently serving as the Ophthalmic & Aesthetics Business Development Manager at RVL Pharmaceuticals, Inc. since April 2021. Nicole successfully launched the first FDA-approved prescription eyedrop for acquired blepharoptosis treatment, with expertise in engaging various medical professionals including ophthalmologists and plastic surgeons. Previously, as a Cardiovascular Sales Representative at Amarin Corporation, Nicole played a key role in the launch of Vascepa’s FDA-approved indication for P-CVR, targeting cardiologists and primary care physicians. Earlier experience includes serving as a Provider Engagement Coordinator at Advantasure, focusing on medical practice documentation improvement, and as a Clinical Allergy Specialist at United Allergy Services, enhancing the effectiveness of immunotherapy processes. Nicole holds a Bachelor of Science in Health Services Administration from Ohio University.